摘要
目的探讨脑钠肽(BNP)在协助判断肺结核合并呼吸衰竭疗效及预后的价值。方法 2013年1月—2014年12月我院收治初治菌阳肺结核合并呼衰共81例,分别在抗结核、呼衰治疗前及2周末行BNP、动脉血气分析及胸部X线检查;按住院号对应随机数字表随机抽取我院同期初治菌阳肺结核无合并呼衰104例作为对照组,采集两组数据进行回顾性病例对照研究。结果肺结核合并呼衰BNP高于单纯肺结核11.4倍(1115.11 pg/m L比97.60pg/m L),全肺结核高于非全肺结核3.4倍(1549.82 pg/m L比449.47 pg/m L)。治疗前BNP与Pa O2、Sa O2和p H值呈负相关,与Pa CO2呈正相关,治疗后两者无相关性。2周末BNP是治疗前0.57倍(632.41 pg/m L比1115.11 pg/m L),死亡组高于存活组8.7倍(3119.63 pg/m L比359.84 pg/m L)。结论肺结核合并呼衰BNP升高,治疗后随病情好转持续下降,有可能成为协助判断疗效及估测预后的指标之一。
Objective Discussion about value of brain natriuretic peptide （BNP） in helping to determine the efficacy and prognostic of pulmonary tuberculosis combine with respiratory failure. Methods 81 cases were admitted from January 2013 to December 2014 in our hospital of early treatment sputum positive pulmonary tuberculosis with respiratory failure. And the cases were carried out BNP, arterial blood gas analysis and chest X-ray before treatment and after two weeks respectively. 104 cases of earlier sputum positive pulmonary tuberculosis accompanied with respiratory failure were randomly drawn according to the corresponding random number of hospitalization as a control group. Two sets of data were collected to conduct retrospective case-control study. Results BNP of pulmonary tuberculosis combine with respiratory failure is 11.4 times higher than that of tuber-culosis alone （1115.11 pg/mL compare 97.60 pg/mL）, the whole TB is 3.4 times higher than non-full-tuberculosis （1549. 82 pg/mL t compare 449.47 pg/mL） . Before treatment, BNP was negatively correlated to PaO2, SaO2 and pH BNP was positively correlated with PaCO2. There was no correlation after treatment between BNP and PaCO2. After two weeks BNP is 0. 57 times of the pre-treatment （632.41 pg/mL compared 1115. 11 pg/mL） . The group of death is 8.7 times higher than the survival group （3119.63 pg/mL compared 359. 84 pg/mL） . Conclusion BNP was significantly increased in patient accompanied tuberculosis with respiratory failure . The condition is continued to decline after treatment. There is likely to be one of the indicators of helping to determine the efficacy and estimate prognosis.
出处
《广州医药》
2016年第1期6-9,共4页
Guangzhou Medical Journal
关键词
肺结核
呼吸衰竭
脑钠肽(BNP)
疗效
预后
Tuberculosis
Respiratory failure
Brain natriuretic peptide （BNP）
Efficacy
Prognosis
